441 related articles for article (PubMed ID: 24699020)
1. The inhibition of aldose reductase attenuates hepatic ischemia-reperfusion injury through reducing inflammatory response.
Li CX; Ng KT; Shao Y; Liu XB; Ling CC; Ma YY; Geng W; Qi X; Cheng Q; Chung SK; Lo CM; Man K
Ann Surg; 2014 Aug; 260(2):317-28. PubMed ID: 24699020
[TBL] [Abstract][Full Text] [Related]
2. Repressor and activator protein accelerates hepatic ischemia reperfusion injury by promoting neutrophil inflammatory response.
Li CX; Lo CM; Lian Q; Ng KT; Liu XB; Ma YY; Qi X; Yeung OW; Tergaonkar V; Yang XX; Liu H; Liu J; Shao Y; Man K
Oncotarget; 2016 May; 7(19):27711-23. PubMed ID: 27050284
[TBL] [Abstract][Full Text] [Related]
3. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N
J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744
[TBL] [Abstract][Full Text] [Related]
4. A role for complement in the enhanced susceptibility of steatotic livers to ischemia and reperfusion injury.
He S; Atkinson C; Evans Z; Ellett JD; Southwood M; Elvington A; Chavin KD; Tomlinson S
J Immunol; 2009 Oct; 183(7):4764-72. PubMed ID: 19752222
[TBL] [Abstract][Full Text] [Related]
5. Plasma membrane-bound G protein-coupled bile acid receptor attenuates liver ischemia/reperfusion injury via the inhibition of toll-like receptor 4 signaling in mice.
Yang H; Zhou H; Zhuang L; Auwerx J; Schoonjans K; Wang X; Feng C; Lu L
Liver Transpl; 2017 Jan; 23(1):63-74. PubMed ID: 27597295
[TBL] [Abstract][Full Text] [Related]
6. Absence of toll-like receptor 4 (TLR4) signaling in the donor organ reduces ischemia and reperfusion injury in a murine liver transplantation model.
Shen XD; Ke B; Zhai Y; Gao F; Tsuchihashi S; Lassman CR; Busuttil RW; Kupiec-Weglinski JW
Liver Transpl; 2007 Oct; 13(10):1435-43. PubMed ID: 17902130
[TBL] [Abstract][Full Text] [Related]
7. The protective function of galectin-9 in liver ischemia and reperfusion injury in mice.
Hirao H; Uchida Y; Kadono K; Tanaka H; Niki T; Yamauchi A; Hata K; Watanabe T; Terajima H; Uemoto S
Liver Transpl; 2015 Jul; 21(7):969-81. PubMed ID: 25931247
[TBL] [Abstract][Full Text] [Related]
8. The roles of lipocalin-2 in small-for-size fatty liver graft injury.
Cheng Q; Ng KT; Xu A; Li CX; Liu XB; Guo DY; Poon RT; Fan ST; Lo CM; Man K
Ann Surg; 2014 Dec; 260(6):1062-72. PubMed ID: 24374540
[TBL] [Abstract][Full Text] [Related]
9. The Inhibition of Aldose Reductase Accelerates Liver Regeneration through Regulating Energy Metabolism.
Li CX; Wang HW; Jiang WJ; Li GC; Zhang YD; Luo CH; Li XC
Oxid Med Cell Longev; 2020; 2020():3076131. PubMed ID: 32190170
[TBL] [Abstract][Full Text] [Related]
10. Endogenous A1 adenosine receptors protect against hepatic ischemia reperfusion injury in mice.
Kim J; Kim M; Song JH; Lee HT
Liver Transpl; 2008 Jun; 14(6):845-54. PubMed ID: 18324658
[TBL] [Abstract][Full Text] [Related]
11. Ischemic preconditioning improves liver tolerance to congestion-reperfusion injury in mice.
Zhang Q; Yan S; Tian Y; Ding Y; Yao J; Chen H; Feng Z; Owusu-Ansah K; Zheng S
J Surg Res; 2014 Jun; 189(1):152-8. PubMed ID: 24589179
[TBL] [Abstract][Full Text] [Related]
12. Endogenous danger signals trigger hepatic ischemia/reperfusion injury through toll-like receptor 4/nuclear factor-kappa B pathway.
Wang H; Li ZY; Wu HS; Wang Y; Jiang CF; Zheng QC; Zhang JX
Chin Med J (Engl); 2007 Mar; 120(6):509-14. PubMed ID: 17439747
[TBL] [Abstract][Full Text] [Related]
13. Mindin deficiency protects the liver against ischemia/reperfusion injury.
Sun P; Zhang P; Wang PX; Zhu LH; Du Y; Tian S; Zhu X; Li H
J Hepatol; 2015 Nov; 63(5):1198-211. PubMed ID: 26165142
[TBL] [Abstract][Full Text] [Related]
14. Human C1 inhibitor attenuates liver ischemia-reperfusion injury and promotes liver regeneration.
Saidi RF; Rajeshkumar B; Shariftabrizi A; Dresser K; Walter O
J Surg Res; 2014 Apr; 187(2):660-6. PubMed ID: 24433870
[TBL] [Abstract][Full Text] [Related]
15. Acute atorvastatin is hepatoprotective against ischaemia-reperfusion injury in mice by modulating eNOS and microparticle formation.
Ajamieh H; Farrell GC; McCuskey RS; Yu J; Chu E; Wong HJ; Lam W; Teoh NC
Liver Int; 2015 Sep; 35(9):2174-86. PubMed ID: 25786512
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment with paricalcitol attenuates inflammation in ischemia-reperfusion injury via the up-regulation of cyclooxygenase-2 and prostaglandin E2.
Hwang HS; Yang KJ; Park KC; Choi HS; Kim SH; Hong SY; Jeon BH; Chang YK; Park CW; Kim SY; Lee SJ; Yang CW
Nephrol Dial Transplant; 2013 May; 28(5):1156-66. PubMed ID: 23229926
[TBL] [Abstract][Full Text] [Related]
17. Recombinant Human Soluble Thrombomodulin Attenuates Hepatic Ischemia and/or Reperfusion Injury by Inhibiting Leukocyte Accumulation in Mice With Normal and Fatty Liver.
Fujii T; Kuriyama N; Hayasaki A; Iizawa Y; Tanemura A; Kato H; Murata Y; Azumi Y; Kishiwada M; Mizuno S; Usui M; Sakurai H; Isaji S
Transplant Proc; 2018 Nov; 50(9):2807-2814. PubMed ID: 30401402
[TBL] [Abstract][Full Text] [Related]
18. Powerful protection against renal ischemia reperfusion injury by T cell-specific NF-κB inhibition.
Xue C; Liu Y; Li C; Li Y; Yang T; Xie L; Zhou P
Transplantation; 2014 Feb; 97(4):391-6. PubMed ID: 24398854
[TBL] [Abstract][Full Text] [Related]
19. Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice.
Teoh NC; Ito Y; Field J; Bethea NW; Amr D; McCuskey MK; McCuskey RS; Farrell GC; Allison AC
Gastroenterology; 2007 Aug; 133(2):632-46. PubMed ID: 17681182
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 18 causes hepatic ischemia/reperfusion injury by suppressing anti-inflammatory cytokine expression in mice.
Takeuchi D; Yoshidome H; Kato A; Ito H; Kimura F; Shimizu H; Ohtsuka M; Morita Y; Miyazaki M
Hepatology; 2004 Mar; 39(3):699-710. PubMed ID: 14999688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
